Werbung
BioXcel Therapeutics Aktie Analyse
| 06.04.18 | BioXcel Therapeutics Outperform | BMO Capital Markets | |
| 02.04.18 | BioXcel Therapeutics overweight | Barclays Capital |
Werbung
Werbung